Parameter SBP group
n=14
non SBP group
n=22
P value
Age(years 50.29 ± 7.03 52.82 ± 10.97 0.05
Sex      
    male 13 18.00000  
    female 1 4.00000  
Blood/serum      
DNA(IU/ml) 88074.14 ± 176261.26 3310201 ± 8332760.094 0.17
ALT(U/L) 59.29 ± 39.48 103.95 ± 136.93 0.04
AST(U/L) 124.143 ± 104.30 118.09 ± 148.31 0.91
TB(umol/L) 420.77 ± 249.56 197.39 ± 209.69 0.64
PTA(%) 31.64 ± 11.58 53.41 ± 26.25 0.02
INR 2.52 ± 0.92 1.80 ± 0.63 0.02
AFP(ng/ml) 20.78 ± 43.29 606.29 ± 2582.24 0.39
WBC(10E9/L) 9.04 ± 5.40 4.51 ± 1.97 <0.01
N(%) 71.46 ± 11.37 59.68 ± 12.57 <0.01
HGB(g/L) 89.29 ± 10.37 101.55 ± 17.87 0.10
PLT(10E9/L) 110.57 ± 72.70 91.45 ± 54.48 0.64
Ascitic fluid      
WBC(10E6/L) 6153.07 ± 20726.75 107.73 ± 68.46 <0.01
N(%) 44.36 ± 27.76 24.38 ± 18.71 <0.01
RBC(10E6/L) 19719.14 ± 51828.80 2615.95 ± 7630.10 0.68
GL(mmol/L) 7.43 ± 3.6 8.05 ± 1.93 0.24
TP(g/L) 18.19 ± 11.66 12.38 ± 9.40 0.23
LDH(U/L) 392.29 ± 1092.09 54.91 ± 26.55 0.01
Aspartate transaminase (AST), alanine aminotransferase (ALT), total bilirubin (TB), prothrombin activity (PTA), international normalized ratio (INR), α-fetoprotein (AFP), platelet count (PLT), hemoglobin (HGB),  white blood cells (WBC), percentage of neutrophilic granulocyte (N), red blood cells (RBC),glucose levels (GL),total protein (TP), Lactate dehydrogenase (LDH) and Serum HBV DNA (DNA) were measured by a quantitative polymerase chain reaction assay (DaAn Diagnostics assay and Roche Amplicor, limit of detectability of 100 IU/mL; Roche Diagnostics, Basel, Switzerland) after admission.
Table 2: Characteristics of “SBP group” and “non-SBP group”